2017
DOI: 10.3748/wjg.v23.i20.3572
|View full text |Cite
|
Sign up to set email alerts
|

Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives

Abstract: The biosynthesis of prostaglandins and thromboxanes has been a focus of interest in the management of many liver diseases. Cyclooxygenases are the enzymes involved in the first step of the biosynthesis of these lipid mediators and selective inhibitors for these isoenzymes as well as pharmacological analogues of prostaglandins have been developed and are currently applied therapeutically. Here we discuss the implications of these enzymes in the onset of metabolic and lipid disorders in the liver and their poten… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
23
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(25 citation statements)
references
References 60 publications
(67 reference statements)
2
23
0
Order By: Relevance
“…Unfortunately, the use of COX-2 inhibitors to prevent cancer is limited by the dangerous cardiovascular side effects that are associated with long-term use [129]. PGE 2 is also implicated in the promotion of many other types of cancer, including cancer of the breast [130], liver [131], lung [132], brain [133] and pancreas [134,135]. This suggests that the Cells 2020, 9, 1018 7 of 28 phenomenon by which inflammation fuels early tumour promotion may be a common feature of cancer development.…”
Section: Evidence Of Tumour-promoting Inflammation In Early Tumourigementioning
confidence: 99%
“…Unfortunately, the use of COX-2 inhibitors to prevent cancer is limited by the dangerous cardiovascular side effects that are associated with long-term use [129]. PGE 2 is also implicated in the promotion of many other types of cancer, including cancer of the breast [130], liver [131], lung [132], brain [133] and pancreas [134,135]. This suggests that the Cells 2020, 9, 1018 7 of 28 phenomenon by which inflammation fuels early tumour promotion may be a common feature of cancer development.…”
Section: Evidence Of Tumour-promoting Inflammation In Early Tumourigementioning
confidence: 99%
“…Among various NF-κB target genes, COX-2 is the best known for the promotion and development of inflammatory conditions including HCC and hepatic fibrosis [38]. COX-2 is an inflammatory molecule, which is induced by various stimulus including cellular stress, inflammatory, and carcinogens, subsequently releasing prostaglandin (PG) promoting tumor development and metastasis [39].…”
Section: Discussionmentioning
confidence: 99%
“…COX-2 is an inflammatory molecule, which is induced by various stimulus including cellular stress, inflammatory, and carcinogens, subsequently releasing prostaglandin (PG) promoting tumor development and metastasis [39]. The liver function has been improved by inhibiting NF-κB induced-activation of proinflammatory factors such as tumor necrosis factor-alpha (TNFα), interleukin-6 (IL-6), and PGE2, and iNOS, COX-2, and matrix metallopeptidase-9 in LPSstimulated RAW 264.7 macrophages as well as in acute liver fibrosis mouse model [38,40,41]. Lignan can inhibit binding affinity between NF-κB and AP-1 transcription factors to interleukins (IL-6 promoter and IL-6) production through p38/NF-κB and AP-1 signaling pathways in cancer [42].…”
Section: Discussionmentioning
confidence: 99%
“…PGE2 is also implicated in the promotion of many other types of cancer, including cancer of the breast [112], liver [113], lung [114], brain [115], and pancreas [116,117]. This suggests that the phenomenon by which inflammation fuels early tumour promotion may be a common feature of cancer development.…”
Section: Evidence Of Tumour-promoting Inflammation In Early Tumourigementioning
confidence: 99%